A resolution designating June 6, 2025, as National Naloxone Awareness Day.
This is a non-binding Senate resolution designating June 6, 2025, as National Naloxone Awareness Day. It highlights the ongoing opioid epidemic and the role of naloxone—an emergency medication that can reverse opioid overdoses and save lives—in reducing fatalities and preventing brain injury. The resolution emphasizes education for the public, families, healthcare professionals, and first responders on naloxone’s benefits and how to administer it, and it identifies barriers to access (notably cost). It urges federal, state, local governments, and private/nonprofit organizations to work together to expand naloxone access and education. It also directs several federal agencies to continue supporting public awareness, harm reduction, and overdose prevention as part of the national drug strategy.
Key Points
- 1Designates June 6, 2025, as National Naloxone Awareness Day.
- 2Asserts naloxone is a safe, effective, life-saving medication that can reverse opioid overdoses and reduce fatalities and potential long-term brain injury; notes the CDC views it as a key tool in preventing overdose deaths.
- 3Stresses the need to educate individuals and communities about naloxone’s benefits and safe administration, and to identify and address barriers to access (including cost).
- 4Calls for collaboration among federal, state, local governments, private sector, and nonprofit organizations to expand access, education, and distribution of naloxone.
- 5Urges relevant federal agencies (e.g., SAMHSA, CDC, ONDCP, DEA) and others involved in the National Drug Control Strategy to continue promoting public awareness, harm reduction, and overdose/poisoning prevention.